St Jude closes 3D cardiac imaging buy
This article was originally published in Clinica
St Jude Medical has completed its $272m acquisition of Endocardial Solutions, a maker of 3D heart imaging technology used in procedures to treat atrial fibrillation. Endocardial Solutions' system is also used to diagnose the condition, which affects around 6 million people worldwide.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.